By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Key Highlights of Medicine today

The Legal Labyrinth of Encrypted Evidence in Europe

Evolutionary Algorithms Outperform Rivals in Complex Data Science Design

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Pathology - A 3D blueprint for ovarian cancer: Decellularised tissue models therapy response

Pathology

A 3D blueprint for ovarian cancer: Decellularised tissue models therapy response

Last updated: February 4, 2026 9:17 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

A 3D blueprint for ovarian cancer: Decellularised tissue models therapy response

Researchers have developed a novel three-dimensional model of high-grade serous ovarian cancer (HGSOC) metastasis using a decellularised peritoneal matrix. This advanced in vitro platform aims to more accurately replicate the complex tumor microenvironment of peritoneal carcinomatosis, a common and challenging pattern of spread. The model provides a valuable tool for investigating disease progression and, critically, for studying the response of metastatic cells to various therapeutic agents, bridging a gap between traditional cell cultures and in vivo studies.

Why it might matter to you: For pathologists focused on tumor biology and diagnostics, this model represents a significant step in translational research. It offers a sophisticated system to pre-clinically test how specific genetic mutations and biomarkers influence treatment efficacy in a realistic tissue context. This could directly inform the development of more targeted molecular diagnostics and help correlate histopathological findings from biopsies with predicted therapeutic outcomes, enhancing personalized treatment strategies.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article A New Frontier in Neuropathic Pain: Targeting TNF in ALS Mice
Next Article The global diagnostic gap in cystic fibrosis revealed by genomic data
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

A New Link in the Chain: How Heart Failure and Diabetes Interact

The structural scaffold of PRC2: A new vulnerability in small cell lung cancer

Sharpening the Scalpel: Tumor Suppressor Co-Mutations Define a New Front in Lung Cancer

The Editorial Blueprint: Navigating the Frontiers of Diagnostic Pathology

The Cellular Mechanics of an Ageing Heart: From Senescence to Stiffness

The Prognostic Power of Counting: CT Metrics in Metastatic Sarcoma

A New Lens on Recovery: Crafting a Quality Scale for Regional Anaesthesia

Metabolic Competition in the Tumor Microenvironment: A New Frontier for Diagnostic Biomarkers

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Gastroenterology
  • Social Sciences
  • Surgery
  • Natural Language Processing
  • Cell Biology
  • Engineering
  • Genetics
  • Immunology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?